BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8796595)

  • 1. Chemotoxicity testing of nonionic radiographic contrast media against the blood-brain barrier.
    Wilson AJ; Evill CA; Pope LM; Sage MR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S331-2. PubMed ID: 8796595
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotoxic effects of low-osmolar contrast media on the blood-brain barrier.
    Evill CA; Wilson AJ; Sage MR
    Invest Radiol; 1990 Sep; 25 Suppl 1():S82-3. PubMed ID: 2283267
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo quantification of the blood-brain barrier injury using magnetic resonance enhancement.
    Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
    Invest Radiol; 1990 Sep; 25 Suppl 1():S80-1. PubMed ID: 2283266
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of nonionic contrast media on the blood-brain barrier. Osmolality versus chemotoxicity.
    Wilson AJ; Evill CA; Sage MR
    Invest Radiol; 1991 Dec; 26(12):1091-4. PubMed ID: 1765444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology of iohexol.
    Shaw DD; Potts DG
    Invest Radiol; 1985; 20(1 Suppl):S10-3. PubMed ID: 3882609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscular and central nervous system side effects of intracarotid contrast media in rabbits.
    Whisson CC; Evill CA; Wilson CA; Sage MR
    Invest Radiol; 1990 Sep; 25 Suppl 1():S90-1. PubMed ID: 2283271
    [No Abstract]   [Full Text] [Related]  

  • 7. The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents.
    Pettersson G; Towart R; Grant D; Thyberg K; Golman K
    Acad Radiol; 2002 May; 9 Suppl 1():S62-4. PubMed ID: 12019897
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurotolerability of nonionic X-ray contrast media. The role of chemotoxicity.
    Luzzani F; Morisetti A; Bussi S; Tirone P; de Haën C
    Invest Radiol; 1996 Jun; 31(6):338-44. PubMed ID: 8761866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some aspects of contrast medium chemotoxicity.
    Dawson P
    Acta Radiol Suppl; 1983; 366():174-9. PubMed ID: 6206688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac effects from addition of sodium ions to nonionic contrast media for coronary arteriography. An investigation of the isolated rabbit heart.
    Bååth L; Almén T; Oksendal A
    Invest Radiol; 1990 Sep; 25 Suppl 1():S137-40. PubMed ID: 2283234
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA.
    Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
    Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural tolerability of commercial preparations of iodinated nonionic monomers and dimers: comparison in an animal model.
    Maly P; Sundgren P; Bååth L
    Acad Radiol; 1996 Aug; 3 Suppl 2():S220-2. PubMed ID: 8796567
    [No Abstract]   [Full Text] [Related]  

  • 13. Electroencephalographic effects of intracisternally injected nonionic x-ray contrast media in rats.
    Adams MD; Ralston WH; Miller JW; Ferrendelli JA
    Invest Radiol; 1990 Sep; 25 Suppl 1():S86-7. PubMed ID: 2283269
    [No Abstract]   [Full Text] [Related]  

  • 14. Vertebral artery injections of methylglucamine diatrizoate 60%, iopromide, and iotrolan in the rabbit.
    Thomson KR; Wells DG; O'Brien K; Tomkins DC; Dixon RG
    Invest Radiol; 1990 Sep; 25 Suppl 1():S88-9. PubMed ID: 2283270
    [No Abstract]   [Full Text] [Related]  

  • 15. The blood-brain barrier: effects of nonionic contrast media with and without addition of Ca2+ and Mg2+.
    Golman K
    Invest Radiol; 1979; 14(4):305-8. PubMed ID: 489270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of ioversol and other contrast media on the blood-brain barrier.
    Motoji N; Shigematsu A; Minegishi A
    Biol Pharm Bull; 1994 Feb; 17(2):257-61. PubMed ID: 8205124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotoxicity of contrast media and clinical adverse effects: a review.
    Dawson P
    Invest Radiol; 1985; 20(1 Suppl):S84-91. PubMed ID: 2579046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of water-soluble contrast agents in upper gastrointestinal tract.
    Gmeinwieser J; Erhardt W; Reimann HJ; Babic R; Speck U; Wenzel-Hora B
    Invest Radiol; 1990 Sep; 25 Suppl 1():S27-8. PubMed ID: 2283247
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
    Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
    Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intravascular contrast media on blood-brain barrier. Comparison between iothalamate, iohexol, iopentol and iodixanol.
    Aulie Michelet A
    Acta Radiol; 1987; 28(3):329-33. PubMed ID: 2958041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.